MRI Fusion Biopsy

    Providing the Latest Prostate Solutions to Hospitals, Surgery Centers & Clinics

    Explore the Advantages of Partnership for MRI Fusion Biopsy Services

    Dedicated partnerships for Urologists and hospitals that reduce upfront service line costs, while offering access to industry leading technology and expand services aligned to growing patient needs.

    Access an integrated MRI/ultrasound fusion biopsy platform and required components without capital investment

    On-site clinical specialist support to help manage pre-procedure preparation and post-procedure logistics

    Versatile technology supports both transrectal and transperineal MRI/US fusion biopsy workflows

    Equipping Organizations with the Ability to Meet Growing Demand for MRI Fusion Biopsy

    MRI can identify suspicious lesions. MRI Fusion Biopsy technology and guidance enable clinicians to deliver targeted biopsy sampling that is mapped and trackable.

    MRI Fusion Biopsy empowers clinicians with leading technology that moves beyond blind, systematic sampling and improves detection of clinically significant disease.

    MRI Fusion Biopsy projected to have

    CAGR
    0 %

    growth through 2030.*

    Specific Coding for MRI Fusion Biopsy Improves Accuracy of Reimbursements

    Prostate biopsy coding has evolved to better differentiate traditional TRUS-guided biopsy workflows from advanced, targeted lesion biopsies that use MRI–ultrasound fusion guidance.

    The updated reimbursement framework supports MRI Fusion Biopsy with clearer, more accurate reporting and aligns reimbursement to the complexity, imaging, and targeting required for fusion biopsy.

    The improvement in accurate reimbursement is beneficial for those expanding their MRI Fusion Biopsy services.

    Advantages of Partnership Model

    Reduce upfront costs, maintain quality, and meet patient demand with a smart partnership model.

    Access to cutting-edge technology: Single integrated, industry-leading MRI Fusion Biopsy device and software without capital investment.

    Specialized support: Skilled on-site technicians manage front-end preparation and back-end logistics.

    Accurate prostate cancer diagnosis: Fusion supports earlier diagnosis and documentation of risk factors supporting patient-centric plans.

    Liaison with Radiology: Collaborate with Radiology as needed; potential to streamline interpretation with an AI solution to improve procedure preparation.

    Ready to expand MRI Fusion Biopsy services with a partnership model designed for growth?

    Talk to an Expert

    * Grand View Research. U.S. Fusion Biopsy Market (2024 – 2030). U.S Fusion Biopsy Market Size & Trends. U.S. Fusion Biopsy Market Size | Industry Report, 2030